11 March 2026 · 11 min read · Arviteni
A practical assessment of AI in care homes: what is working now, what is still experimental, and how to navigate UK data sovereignty, GDPR, and the evolving AI governance landscape.
AI is no longer a concept sitting on the horizon for care homes. It is here, being used in services across the UK, and producing results that range from genuinely useful to actively risky. The problem is that most of the conversation around AI in care is driven either by technology vendors with things to sell or by regulatory bodies moving cautiously on guidance. Neither gives care managers and providers what they actually need: an honest account of what is working, what is not, and what compliance looks like in 2026.
This post attempts to provide that honest account.
The most useful AI tools deployed in care homes in 2026 are not the ones making clinical decisions. They are the ones removing administrative friction from the people responsible for delivering care.
Rostering and rota optimisation is perhaps the clearest example. Dynamic rostering tools use AI to match shift patterns against staff availability, care package requirements, travel distances, and skills matrices. The output is not a rota a manager constructed manually over several hours on a Sunday evening. It is a starting point that accounts for constraints a human would take hours to consider. Managers still approve and adjust, but the cognitive load of building a compliant, efficient rota from scratch is substantially reduced. The business case here is straightforward: reduced agency use, fewer compliance gaps from uncovered shifts, and less time spent by senior staff on administrative coordination.
Care documentation and AI scribes are gaining traction quickly. Tools that listen to (or read structured prompts from) handover conversations and convert them into draft care notes have moved from pilot projects to operational deployment in a number of services. The quality of the output varies, and anything used for legal or safeguarding documentation still requires careful human review. But for routine daily notes, where the barrier is often simply finding the time to sit down and type, AI-assisted documentation genuinely changes what is feasible for frontline workers.
Referral processing and administrative triage are also well-suited to AI. Parsing incoming referral information, extracting key fields, flagging missing documentation, and routing enquiries to the right person are tasks where AI performs reliably and frees up care coordination time for the work that requires human judgement.
Pain assessment tools such as PainChek use facial recognition AI to assess pain in residents who cannot self-report, including those living with advanced dementia. This is a validated, regulated tool with a clinical evidence base. It is not speculative. Care homes using PainChek have recorded measurable improvements in pain management outcomes and medication reviews.
Acoustic monitoring for distress detection, bed exit alerts, and fall detection is a different category: ambient AI that monitors sound continuously and alerts staff to specific events. The regulatory and consent picture here requires careful thought, particularly for residents who lack capacity, but for services that have worked through that process, the technology provides a layer of observation that is not otherwise achievable on a night shift with one or two workers on a large floor.
Being clear about limitations is as important as describing what works.
Autonomous clinical decision-making is not ready, and any vendor suggesting otherwise should be treated with significant scepticism. AI tools can surface information, flag anomalies, and provide prompts to clinicians and care managers. They cannot and should not be substituting for professional clinical judgement on care planning, medication management, or safeguarding decisions. The regulatory and ethical framework for that does not exist yet, and the liability position is correspondingly unclear.
AI-generated care plans without meaningful human oversight fall into the same category. A tool that produces a draft care plan from assessed needs can be genuinely useful, provided a competent practitioner reviews, adjusts, and takes ownership of the output. A tool used to generate care plans that are signed off without substantive review is not saving time: it is creating a compliance and quality risk while obscuring it.
Predictive deterioration models are in active development and some are showing promising results in hospital settings. Their application in care homes, where the underlying data is less structured and less consistently recorded, is not yet at a stage where operational reliance is appropriate.
Emotion or sentiment analysis tools that claim to assess resident wellbeing from speech patterns or facial expression are speculative in their current form and raise significant consent and dignity concerns. Treat any such tool with caution until there is a meaningful evidence base specific to care settings.
AI governance has moved to the centre of the regulatory conversation in 2026, and care providers cannot treat it as someone else's problem.
The EU AI Act classifies AI systems used in social care as high-risk applications. While the UK is not bound by the EU AI Act post-Brexit, UK providers operating or procuring from EU vendors are affected, and the ICO and government have signalled that UK AI regulation will move in a broadly similar direction. High-risk classification means mandatory conformity assessments, technical documentation, human oversight requirements, and transparency obligations. Any vendor supplying AI tools to UK care providers should be able to demonstrate how their product addresses these requirements.
The ICO's guidance on AI and data protection is now comprehensive and clearly applicable to care settings. Key requirements include: transparency to residents and families about how AI processes their personal data; data minimisation in AI systems (only processing the data actually needed); and maintaining meaningful human oversight over automated decisions that significantly affect individuals. The ICO's expectation is that AI tools are included in your data flow mapping, and that their use is addressed in your privacy notices and Data Protection Impact Assessments.
CQC's position has evolved from general interest to active assessment. Inspectors in 2026 are asking questions about technology in care, including how AI-assisted tools are governed, how staff are trained to use them appropriately, and how oversight of AI-generated outputs is maintained. "The computer said so" is not an acceptable answer to questions about care planning, medication management, or safeguarding decisions. The responsible use of AI is increasingly something CQC expects to see evidenced, not just described.
DSPT (the Data Security and Protection Toolkit) requires care providers to account for all systems that process personal data, including AI tools. A tool that was quietly adopted by a team member without going through procurement or information governance review is a DSPT gap. See our post on cyber security in adult social care for the broader context here.
One of the most common AI-related risks we see in care organisations right now is not a sophisticated technology failure. It is staff using general-purpose AI tools, such as ChatGPT or Gemini, for work tasks that involve resident information.
The problem is not that staff are trying to do harm. They are trying to work more efficiently. Someone struggling to find the right phrasing for a difficult safeguarding referral, or trying to summarise a long handover note quickly, finds a text tool that helps them. The risk comes from what they do not know about how that tool works.
General-purpose consumer AI tools were not built for regulated care environments. They have no audit trail in any sense meaningful to CQC or ICO. Data entered into them may be used to train future models, depending on the provider's terms of service and whether the user has a managed enterprise account. They have no knowledge of UK regulatory context: a response that sounds confident and helpful may be completely inconsistent with the Care Act, GDPR, or CQC fundamental standards. There is no data sovereignty: you have no meaningful control over where the data is processed or stored.
The specific risk for care is that residents' personal data, sometimes including sensitive health and social care information, ends up in systems that your organisation has no contract with, no data processing agreement covering, and no ability to audit or retrieve from. That is a data breach, even if the information was not accessed by any malicious party.
The answer is not to ban AI outright, which will not work and which closes off genuine efficiencies. The answer is to provide staff with AI tools that are purpose-built for regulated environments, with the governance infrastructure that consumer tools lack.
Data sovereignty has become a practical question for care providers, not just a technical one.
Where your data is hosted determines which legal frameworks govern it, what access requests a government could make of a cloud provider, and what assurances you can give to residents, families, and commissioners about how their information is managed.
For care providers, the relevant considerations are:
Resident data is special category personal data under UK GDPR. The bar for processing it is higher, and the obligations on controllers are more significant. Hosting that data with a provider whose infrastructure is primarily outside the UK, or whose parent company is incorporated in a jurisdiction with broad government data access powers, creates a compliance exposure that is not always fully understood at procurement stage.
NHS-connected services, including primary care liaison, medication supply, and some funded care packages, increasingly require evidence that data remains within UK-controlled infrastructure. This will become a more common commissioning requirement as integrated care systems mature.
UK-hosted AI systems, where model inference and data processing occur within UK infrastructure, allow you to make unambiguous representations to regulators and commissioners about where resident data goes. For a sector where trust is a core operating requirement, that matters.
When evaluating any AI tool, ask the vendor specifically: where is the data processed? Where are the models hosted? What happens to the data after inference? Does the vendor use customer data to train or fine-tune models? The answers to these questions are not always in the marketing materials.
The care providers that are getting the most from AI right now are not those that have adopted the most tools. They are those that have been selective, governance-first, and honest about where human oversight is non-negotiable.
A sensible approach in 2026 looks roughly like this.
Start with administrative use cases: rostering, documentation assistance, referral processing. These deliver real efficiency gains, the risk of a poor output is lower than in clinical contexts, and the compliance picture is more straightforward.
Before deploying any AI tool, include it in your information governance review: data flow mapping, DPA with the vendor, DPIA where appropriate, and a privacy notice update. This is not optional if you want to maintain DSPT compliance and avoid ICO exposure.
Train staff on appropriate use, specifically including what not to use general-purpose tools for. The policy cannot just say "no AI tools not approved by the organisation." It needs to explain why, and it needs to give staff an approved alternative.
Maintain meaningful human oversight of AI outputs, particularly for anything that feeds into care plans, safeguarding decisions, or clinical documentation. Document that oversight in your processes, not just in policy.
Review your AI use regularly. This is a rapidly evolving space. A tool that was appropriate for its stated purpose six months ago may have changed its terms of service, its data hosting arrangements, or its functionality. Treat AI tools like any other significant software: subject to annual review and active vendor management.
AI in care is genuinely useful when it is deployed thoughtfully, with appropriate governance, and in the right parts of the operation. It is a source of compliance risk and reputational exposure when it is not.
If your organisation is trying to work out where AI fits, what governance you need to put in place, or how to evaluate tools against regulatory requirements, our AI Consulting service is built specifically for care providers navigating these questions. We do not sell AI tools: we help you make good decisions about them.
If you are looking for an AI assistant that is purpose-built for care, hosted in the UK, and designed around the regulatory requirements care providers actually face, Clara AI was built for exactly this context. It gives your team the efficiency benefits of AI-assisted working without the data sovereignty, audit trail, and compliance gaps that come with general-purpose tools.
The question for care providers in 2026 is not whether to use AI. It is how to use it well.